about
Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical EffectsCardioprotective Effects of Oral Trimetazidine in Diabetic Patients With Anterior Wall Myocardial Infarction Treated with Thrombolysis.Angiographic and Clinical Impact of Successful Manual Thrombus Aspiration in Diabetic Patients Undergoing Primary PCI.Prognostic impact of intensive statin therapy on N-terminal pro-BNP level in non-ST-segment elevation acute myocardial infarction patients.Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.Atropine first is safer than conventional atropine administration in older people undergoing dobutamine stress echocardiography.Value of two-dimensional strain imaging in prediction of myocardial function recovery after percutaneous revascularization of infarct-related artery.Relation between ischaemic threshold measured during dobutamine stress echocardiography and coronary angiographic features.Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention.Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary interventionCardioprotective effects of intracoronary adenosine in diabetic patients undergoing elective percutaneous coronary intervention
P50
Q36334449-3DF33492-DBD8-4EB8-AF97-86B8BCDBDA01Q37711313-B7C9CB91-D562-4DB7-9182-C634C7B9FE40Q37718905-24ED2229-4975-4A60-846A-8E2688696CFBQ38622615-373AF88C-B8CE-482C-8DB2-6D4E3D419737Q39454515-256EFF4B-B27E-4A55-8EC9-0F5D241F15F7Q46158352-4985F6F7-1454-4D91-B822-56490A84B6A6Q46815059-F7BC5590-96A1-4C91-BE6F-EA2FA8CD43AEQ53842928-AEBF4125-81B4-401E-B2BA-CB8947A22025Q55071506-4DE4DD3A-5AA5-4EB4-8D9A-A14E7A2A0EC9Q88076493-ABCFDF34-6D64-4EFC-998B-AEC340C5CE2DQ95577738-A40E5853-CB90-4302-897F-07C23909D965
P50
description
researcher (ORCID 0000-0002-9981-0040)
@en
wetenschapper
@nl
name
Mohamed Shehata
@en
Mohamed Shehata
@nl
type
label
Mohamed Shehata
@en
Mohamed Shehata
@nl
prefLabel
Mohamed Shehata
@en
Mohamed Shehata
@nl
P31
P496
0000-0002-9981-0040